URGN
UroGen Pharma Ltd.
$29.46
+$0.57(+1.97%)
55
Overall
40
Value
66
Tech
60
Quality
Market Cap
$1.38B
Volume
600.04K
52W Range
$3.42 - $30.45
Target Price
$36.11
EPS Estimates Overview
| Current Quarter | $-0.42 | Next Quarter | $-0.16 |
| Current Year | $-0.98 | Next Year | $1.4 |
| QoQ Growth | +61.9% | YoY Growth | +242.9% |
| 3Y EPS CAGR | +12.8% | Target Price | $36.11 |
| Consensus | Buy | Upside | +22.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $29.46 | +2.0% | 600.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |